Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 USD | +1.68% | +12.04% | +52.59% |
Evolution of the average Target Price on Adaptimmune Therapeutics plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Adaptimmune Therapeutics plc
Barclays | |
EF Hutton | |
Guggenheim | |
Wells Fargo Securities | |
Mizuho Securities | |
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- ADAP Stock
- Consensus Adaptimmune Therapeutics plc